Biotii is actively pursuing genetically engineered microorganisms that express cannabinoid profiles identical to those found in nature, at a fraction of the cost of current cannabis production methods and with more consistent production quality.
Read More
The company currently has ongoing cannabis extract research and development targeting four specific health issues, COPD, Type 2 Diabetes, Cancer Pain Management and one additional health issue.
Read More
KALY is developing a proprietary extract that improves upon the cannabis treatments currently approved by the FDA.
Read More
Kali-Extracts, through its patented cannabis extraction process, is developing a variety of treatments for various health issues.
Read More
The FDA provided feedback supportive of CURE’s clinical development plans for its CUREfilm Blue, a soluble thin film for oral administration of sildenafil citrate (Viagra™) to treat erectile dysfunction (ED).
Read More
Get stock alerts, news & related alerts straight to your inbox!